Ventavis and Levaquin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ventavis (iloprost) and Levaquin (levofloxacin). Common drug interactions include dizziness among females and ascites among males.

The phase IV clinical study analyzes what interactions people have when they take Ventavis and Levaquin. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Ventavis?

Ventavis has active ingredients of iloprost. eHealthMe is studying from 11,982 Ventavis users. Check the latest studies of Ventavis.

What is Levaquin?

Levaquin has active ingredients of levofloxacin. It is often used in sinusitis. eHealthMe is studying from 56,638 Levaquin users. Check the latest studies of Levaquin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

11 people who take Ventavis and Levaquin together, and have interactions are studied.

Ventavis and Levaquin drug interactions.

What are the common drug interactions of Ventavis and Levaquin, by gender? *:

female:

  1. Dizziness
  2. Blood iron decreased
  3. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  4. Bronchitis chronic (inflammation of the mucous membrane in the bronchial tubes- chronic)
  5. Cough
  6. Cystitis (inflammation of the wall of the bladder)
  7. Dyspnoea (difficult or laboured respiration)
  8. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  9. Hepatic steatosis (fatty liver disease)
  10. Malaise (a feeling of general discomfort or uneasiness)

male:

  1. Ascites (accumulation of fluid in the abdominal cavity)
  2. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  3. Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
  4. Hypotension (abnormally low blood pressure)
  5. Lung neoplasm (tumour of lung)
  6. Oesophageal varices haemorrhage (bleeding from extremely dilated sub-mucosal veins in the lower third of the oesophagus)
  7. Peritonitis bacterial (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs by bacterial)
  8. Pleural effusion (water on the lungs)
  9. Portal hypertension (increase in the blood pressure within a system of veins called the portal venous system)
  10. Portal hypertensive gastropathy (changes in the mucosa of the stomach in patients with portal hypertension;)

What are the common drug interactions of Ventavis and Levaquin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Dizziness
  2. Blood iron decreased
  3. Oropharyngeal pain
  4. Oxygen saturation decreased
  5. Platelet count decreased
  6. Productive cough
  7. Ascites (accumulation of fluid in the abdominal cavity)
  8. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  9. Clostridial infection (infectious conditions by clostridium bacteria)
  10. Confusional state

What are the existing conditions these people have? *

  1. Pulmonary Hypertension (increase in blood pressure in the lung artery): 5 people, 45.45%
  2. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 36.36%
  3. Systemic Sclerosis (Scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin): 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Ventavis and Levaquin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ventavis and Levaquin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ventavis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Levaquin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ventavis and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Levaquin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on iloprost and levofloxacin (the active ingredients of Ventavis and Levaquin, respectively), and Ventavis and Levaquin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: